Walgreens Boots Alliance Inc (WBA) Shares Sold by Venturi Wealth Management LLC
Venturi Wealth Management LLC trimmed its holdings in Walgreens Boots Alliance Inc (NASDAQ:WBA) by 45.6% during the third quarter, HoldingsChannel reports. The firm owned 19,909 shares of the pharmacy operator’s stock after selling 16,685 shares during the period. Venturi Wealth Management LLC’s holdings in Walgreens Boots Alliance were worth $1,525,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds have also added to or reduced their stakes in the business. Hudock Capital Group LLC lifted its stake in Walgreens Boots Alliance by 0.5% in the 2nd quarter. Hudock Capital Group LLC now owns 1,306 shares of the pharmacy operator’s stock worth $102,000 after purchasing an additional 6 shares in the last quarter. Northern Capital Management LLC lifted its stake in Walgreens Boots Alliance by 0.4% in the 2nd quarter. Northern Capital Management LLC now owns 6,635 shares of the pharmacy operator’s stock worth $520,000 after purchasing an additional 25 shares in the last quarter. MAI Capital Management lifted its stake in Walgreens Boots Alliance by 0.6% in the 2nd quarter. MAI Capital Management now owns 5,272 shares of the pharmacy operator’s stock worth $413,000 after purchasing an additional 34 shares in the last quarter. Truepoint Inc. lifted its stake in Walgreens Boots Alliance by 0.5% in the 2nd quarter. Truepoint Inc. now owns 8,614 shares of the pharmacy operator’s stock worth $698,000 after purchasing an additional 39 shares in the last quarter. Finally, Meridian Wealth Management LLC raised its position in shares of Walgreens Boots Alliance by 1.4% during the 1st quarter. Meridian Wealth Management LLC now owns 3,550 shares of the pharmacy operator’s stock valued at $295,000 after buying an additional 50 shares during the period. 61.18% of the stock is currently owned by institutional investors and hedge funds.
Several analysts have recently commented on the stock. Pivotal Research set a $73.00 price target on shares of Walgreens Boots Alliance and gave the company a “hold” rating in a research report on Friday, January 5th. ValuEngine raised shares of Walgreens Boots Alliance from a “hold” rating to a “buy” rating in a research report on Thursday, January 4th. Robert W. Baird reaffirmed a “buy” rating and set a $82.00 price target on shares of Walgreens Boots Alliance in a research report on Thursday, January 4th. Evercore ISI assumed coverage on shares of Walgreens Boots Alliance in a research report on Thursday, January 4th. They set an “outperform” rating and a $80.00 price target on the stock. Finally, Loop Capital set a $90.00 price target on shares of Walgreens Boots Alliance and gave the company a “buy” rating in a research report on Wednesday, January 3rd. One research analyst has rated the stock with a sell rating, eight have assigned a hold rating, fifteen have assigned a buy rating and one has assigned a strong buy rating to the stock. The company presently has an average rating of “Buy” and a consensus price target of $86.05.
Walgreens Boots Alliance (NASDAQ:WBA) last announced its earnings results on Thursday, January 4th. The pharmacy operator reported $1.28 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.27 by $0.01. The company had revenue of $30.74 billion for the quarter, compared to analyst estimates of $30.39 billion. Walgreens Boots Alliance had a return on equity of 19.15% and a net margin of 3.19%. The firm’s quarterly revenue was up 7.9% compared to the same quarter last year. During the same quarter in the previous year, the company earned $1.10 earnings per share. equities research analysts expect that Walgreens Boots Alliance Inc will post 5.59 EPS for the current year.
The company also recently announced a quarterly dividend, which was paid on Tuesday, December 12th. Shareholders of record on Monday, November 13th were given a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a yield of 2.18%. The ex-dividend date of this dividend was Friday, November 10th. Walgreens Boots Alliance’s payout ratio is 44.20%.
Walgreens Boots Alliance declared that its board has approved a stock buyback program on Wednesday, October 25th that allows the company to repurchase $1.00 billion in shares. This repurchase authorization allows the pharmacy operator to reacquire shares of its stock through open market purchases. Stock repurchase programs are usually an indication that the company’s leadership believes its stock is undervalued.
In other Walgreens Boots Alliance news, Director John Anthony Lederer purchased 20,000 shares of the company’s stock in a transaction on Thursday, October 26th. The stock was acquired at an average price of $67.00 per share, for a total transaction of $1,340,000.00. Following the completion of the purchase, the director now directly owns 50,000 shares in the company, valued at approximately $3,350,000. The purchase was disclosed in a filing with the SEC, which is available through this link. Also, Director William C. Foote sold 2,736 shares of the business’s stock in a transaction on Thursday, November 2nd. The stock was sold at an average price of $67.37, for a total transaction of $184,324.32. Following the completion of the transaction, the director now owns 16,415 shares of the company’s stock, valued at approximately $1,105,878.55. The disclosure for this sale can be found here. 14.80% of the stock is owned by insiders.
COPYRIGHT VIOLATION NOTICE: This story was reported by Watch List News and is owned by of Watch List News. If you are accessing this story on another domain, it was illegally stolen and republished in violation of international trademark & copyright legislation. The original version of this story can be viewed at https://www.watchlistnews.com/walgreens-boots-alliance-inc-wba-shares-sold-by-venturi-wealth-management-llc/1800701.html.
About Walgreens Boots Alliance
Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).
Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.